EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Proton Pump Inhibitor Use and Incident Epilepsy in the UK Biobank: Evidence From Pharmacovigilance and Multi‐Omics Analyses

Minghao Li, Yiqian Li, Yuxi Zhang, Balkissou Seebo Saibou, Yifei Chen, Jiayi Xing, Chao Jin, Yuchen Xu, Jiahe Lin, Xinshi Wang

CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)

DOI: 10.1002/cns.71223 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Aims Proton pump inhibitors (PPIs) are widely used, but their association with incident epilepsy remains uncertain. We examined this association in the UK Biobank and integrated evidence from pharmacovigilance and multi‐omics. Methods We included 492,858 UK Biobank participants without epilepsy at baseline. Cox models, age‐ and sex‐stratified analyses, active‐comparator analyses against H2RA users, propensity score matching, competing‐risk models, and sensitivity analyses were performed. FAERS disproportionality, Olink proteomics, and NMR metabolomics provided supportive evidence. Results Baseline PPI use was associated with incident epilepsy after full adjustment (HR 1.43, 95% CI 1.29–1.59) and in the PPI‐H2RA propensity score‐matched analysis (HR 1.41, 95% CI 1.03–1.94). In the GP‐linked subset, requiring an ASM prescription within 365 days after diagnosis yielded HR 1.47 (95% CI 1.07–2.02). FAERS showed a PPI‐epilepsy reporting signal (ROR 1.70, 95% CI 1.61–1.79). Proteomic and metabolomic analyses identified immune‐inflammatory and metabolic associations. Conclusion Baseline PPI use was associated with incident epilepsy in the UK Biobank. Active‐comparator, outcome‐definition, and prescription‐supported analyses supported the primary association. Pharmacovigilance and molecular findings provided complementary evidence but did not establish causality.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →